Benefits of Taking Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease: A Systematic Review. The gene discussed is SLC5A2; the disease is type 2 diabetes mellitus.